cancer
Conditions
Interventions
Intervention participants will receive a single session of a lecture-based cancer education program. The lecture content will be developed based on cancer education materials produced by the Ministry
activities will be limited to their routine academic and daily learning behaviors. Outcome assessments will be conducted at the same time points as in the intervention group. The T1 survey will be ad
Sponsors
University of Miyazaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Be a student aged 18 or older at the time of consent acquisition (2) Have no history of cancer (3) Be able to read and write in Japanese (4) Have received sufficient explanation regarding participation in this study, fully understand it, and have consented of their own free will
Exclusion criteria
Exclusion criteria: (1) Individuals who are deemed unable to participate in the educational intervention or complete the questionnaires due to mental or physical reasons (2) Individuals aged 36 or older (the upper age limit for participation is 35) (3) Individuals who are judged unsuitable as research participants by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the change in the Japanese Cancer Stigma Scale (J-CASS) score following the educational intervention. The same scale will be administered at three time points: baseline (pre-intervention: T0), immediately after the intervention (T1), and one month after the intervention (T2). The reduction in the stigma score at T1 will be the primary endpoint for comparison. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cancer stigma Cancer stigma will be assessed at T0, T1, and T2, and changes in scores from T0 to T2 will be compared to evaluate the sustainability of the intervention effect. Cancer-related knowledge Cancer-related knowledge will be assessed using the Japanese Cancer Intelligence Quotient Knowledge domain (JCIQ-K) at T0, T1, and T2. Changes in scores at T1 and T2 will be examined. Cancer literacy Cancer literacy will be assessed using the Japanese Cancer Intelligence Quotient Literacy domain (JCIQ-L) at T0, T1, and T2, and changes in scores over time will be evaluated. Health literacy Health literacy will be assessed using the eHealth Literacy Scale (eHEALS) and the European Health Literacy Survey Questionnaire short form (HLS-EU-Q12) at T0 and T2, and changes in scores will be examined. Loneliness Loneliness will be assessed using the Japanese version of the UCLA Loneliness Scale (Version 3), short form, at T0 and T2, and changes in scores will be explored. Social support Perceived social support will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS) at T0 and T2, and changes in scores will be examined. Feasibility outcomes Feasibility will be assessed based on response and follow-up rates, missing data, questionnaire completion time, comprehensibility of survey items, and estimates of effect sizes and standard deviations to inform the design of a future full-scale trial. | — |
Countries
Japan
Contacts
Public ContactKinoshita Yumiko
University of Miyazaki Department of Integrated Clinical Nursing Science, School of Nursing, Faculty of Medicine
Outcome results
None listed